Day One Biopharmaceuticals Stock Jumps on Renewed M&A Rumors
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Already have an account? Sign in.
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
AI-powered 60-second scans could transform preventive healthcare.
Vail Resorts hires takeover-defense bankers as it faces pressure from activist investors, billionaire Matthew Prince, labor unions, and poor ski seasons.
Cecile Guegan named Interim CFO as the company reaffirms its 2026 guidance.